Infective endocarditis is a disease with high mortality and morbidity, generally caused by a wide range of organisms. Prophylaxis with penicillins, cefalosporins, macrolides, or vancomycin is highly recommended for the patients with endocarditis, prosthetic heart valves. An 83-year-old man admitted with fever, fatigue, and joint pain and reported dental intervention following amoxicillin prophylaxis fortyfive days ago. Patient history indicated acute rheumatoid arthritis, bacterial endocarditis, and mitral and aortic valve replacement. S. Sanguinis was detected in the blood culture of the patient, which was resistant to penicillin and ampicillin. He was given meropenem, the clinical status was improved and no microorganisms were detected in two follow-up blood cultures. Endocarditis prophylaxis should be individualized considering the globally high penicillin resistance, especially for the patients with prosthetic valves and/or infective endocarditis history. In addition, to decrease the bacterial load of the oral flora before elective dental or respiratory intervention is recommended with antibiotic prophylaxis.
Keywords: Infective endocarditis; antibiotic prophylaxis; antibiotic resistance; S. sanguinis
- Alkhawam H, Sogomonian R, Zaiem F, Vyas N, El-Hunjul M, Jolly J, et al. Morbidity and mortality of infective endocarditis in a hospital system in New York City serving a diverse urban population. J Investig Med. 2016;64(6):1118-23. [Crossref] [PubMed]
- Taubert KA, Wilson W. Is endocarditis prophylaxis for dental procedures necessary? Heart Asia. 2017;9(1):63-7. [Crossref] [PubMed] [PMC]
- Chun S, Huh HJ, Lee NY. Species-specific difference in antimicrobial susceptibility among viridans group streptococci. Ann Lab Med. 2015;35(2):205-11. [Crossref] [PubMed] [PMC]
- Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. [Crossref] [PubMed]
- Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective Endocarditis in Adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-86. [Crossref] [PubMed]
- Sexton DJ, Chu WH (author), Otto CM (section editor), Baron EL, Yeon SB (deputy editor). Antimicrobial prophylaxis for prevention of bacterial endocarditis. Otto CM, ed. UpToDate 2019. https://www.uptodate.com/contents/antimicrobial-prophylaxis-for-the-prevention-of-bacterial-endocarditis?search=antimicrobial%20prophylaxis%20for%20prevention%20of%20bacterial%20endocarditis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 Access date: 16 March, 2019.
- Sexton DJ, Chu VH (author), Calderwood SB (section editor), Baron EL (deputy editor). Epidemiology, risk factors, and microbiology of infective endocarditis. Calderwood SB, Ed. UpToDate 2019. https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis?topicRef=2143&source=see_link Access date: 16 March, 2019.
- Al-Omari A, Cameron DW, Lee C, Corrales-Medina VF. Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review. BMC Infect Dis. 2014;14:140. [Crossref] [PubMed] [PMC]
- Süzük S, Kaşkatepe B, Çetin M. Antimicrobial susceptibility against penicillin, ampicillin, and vancomycin of viridans group Streptococcus in oral microbiota of patients at risk of infective endocarditis. Infez Med. 2016;24(3):190-3.
- Sayın-Kutlu S, Ökke D, Demir M, Tepeli E, Sarı İ. [Penicilin susceptibility of viridans group streptococci isolated from the oropharynx of patients with hematological malignancy]. Klimik Dergisi. 2012;25:6-9. [Crossref]
- Ergin A, Eser ÖK, Hasçelik G. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases. New Microbiol. 2011;34(2):187-93.
- Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015;385(9974):1219-28. [Crossref]
- Limeres Posse J, Álvarez Fernández M, Fernández Feijoo J, Medina Henríquez J, Lockhart PB, Chu VH, et al. Intravenous amoxicillin/clavulanate for the prevention of bacteraemia following dental procedures: a randomized clinical trial. J Antimicrob Chemother. 2016;71(7):2022-30. [Crossref] [PubMed]
- Maharaj B, Coovadia Y, Vayej AC. A comparative study of amoxicillin, clindamycin and chlorhexidine in the prevention of post-extraction bacteremia. Cardiovasc J Afr. 2012;23(9):491-4. [Crossref] [PubMed] [PMC]
- Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al; ESC Committee for Practice Guidelines (CPG). Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369-413.
.: Process List